In today’s recent session, 0.46 million shares of the Replimune Group Inc (NASDAQ:REPL) have been traded, and its beta is 1.28. Most recently the company’s share price was $12.36, and it changed around $2.22 or 21.94% from the last close, which brings the market valuation of the company to $931.58M. REPL at last check was trading at a discount to its 52-week high of $17.00, offering almost -37.54% off that amount. The share price’s 52-week low was $4.92, which indicates that the recent value has risen by an impressive 60.19% since then. We note from Replimune Group Inc’s average daily trading volume that its 10-day average is 0.69 million shares, with the 3-month average coming to 801.14K.
Replimune Group Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.12. If we narrow it down even further, the data shows that 0 out of 8 analysts rate the stock as a Sell; another 5 rate it as Overweight. Among the rest, 0 recommended REPL as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Replimune Group Inc is expected to report earnings per share of -0.72 for the current quarter.
Replimune Group Inc (NASDAQ:REPL) trade information
Instantly REPL has been showing a green trend so far today with a performance of 21.94% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 13.13 on recent trading dayincreased the stock’s daily price by 5.86%. The company’s shares are currently up 2.11% year-to-date, but still up 13.54% over the last five days. On the other hand, Replimune Group Inc (NASDAQ:REPL) is 5.50% up in the 30-day period. We can see from the shorts that 6.61 million shares have been sold at a short interest cover period of 8.77 day(s).
The consensus price target as assigned by Wall Street analysts is $19, which translates to bulls needing to increase their stock price by 34.95% from its current value. Analyst projections state that REPL is forecast to be at a low of $19 and a high of $19.
Replimune Group Inc (REPL) estimates and forecasts
Replimune Group Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 25.03 percent over the past six months and at a 10.19% annual growth rate that is well below the industry average of 16.50%.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -19.52%.
REPL Dividends
Replimune Group Inc’s next quarterly earnings report is expected to be released in February.
Replimune Group Inc (NASDAQ:REPL)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 4.18% of Replimune Group Inc shares, and 91.95% of them are in the hands of institutional investors. The stock currently has a share float of 95.96%. Replimune Group Inc stock is held by 209.0 institutions, with BAKER BROS. ADVISORS LP being the largest institutional investor. By 2024-06-30, it held 15.0899% of the shares, which is about 10.05 million shares worth $90.41 million.
PRICE T ROWE ASSOCIATES INC /MD/, with 13.8742% or 9.24 million shares worth $83.13 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Price (T.Rowe) New Horizons Fund and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Sep 30, 2024 . The former held 4.39 shares worth $50.87 million, making up 6.42% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 2.02 shares worth around $23.43 million, which represents about 2.96% of the total shares outstanding.
